SEARCH

SEARCH BY CITATION

References

  • 1
    Ullmann AJ, Cornely OA, Donnelly JP et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect 2012; 18: 18.
  • 2
    Cuenca-Estrella M, Verweij PE, Arendrup MC et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012; 18: 918.
  • 3
    Cornely OA, Basseti M, Calandra T et al. ESCMID guideline for the diagnosis and management of Candida diseases: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18: 1937.
  • 4
    Hope WW, Castagnola E, Groll AH et al. ESCMID guideline for the diagnosis and the management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect 2012; 18: 3852.
  • 5
    Ullmann AJ, Akova M, Herbrecht R et al. ESCMID guideline for the diagnosis and the management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect 2012; 18: 5367.
  • 6
    Lortholary O, Petrikkos G, Akova M et al. ESCMID guideline for the diagnosis and the management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect 2012; 18: 6877.
  • 7
    Cornely OA, Arikan-Akdagli S, Dannaoui E et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis. Clin Microbiol Infect 2014; 20 (Supplement 2). In press.
  • 8
    Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503535.
  • 9
    Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327360.
  • 10
    Maertens J, Marchetti O, Herbrecht R et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3–2009 update. Bone Marrow Transplant 2011; 46: 709718.
  • 11
    Marchetti O, Lamoth F, Mikulska M et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47: 846854.
  • 12
    Skiada A, Lanternier F, Groll AH et al. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2013; 98: 492504.
  • 13
    Arendrup MC, Bille J, Dannaoui E, Ruhnke M, Heussel CP, Kibbler C. ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia. Bone Marrow Transplant 2012; 47: 10301045.
  • 14
    GRADE WORKING GROUP. Gradeworkinggroup.org [homepage in the Internet]. [place unknown]: The GRADE working group; c2005-2013 [updated July 02 2013; last accessed July 15 2013]. Available at: http://www.gradeworkinggroup.org/.
  • 15
    Reboli AC, Rotstein C, Pappas PG et al. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 2007; 356: 24722482.
  • 16
    Skiada A, Pagano L, Groll A et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011; 17: 18591867.
  • 17
    Vehreschild JJ, Birtel A, Vehreschild MJ et al. Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013; 39: 310324.
  • 18
    Nivoix Y, Launoy A, Lutun P et al. Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. J Antimicrob Chemother 2012; 67: 25062513.
  • 19
    Patel M, Kunz DF, Trivedi VM, Jones MG, Moser SA, Baddley JW. Initial management of candidemia at an academic medical center: evaluation of the IDSA guidelines. Diagn Microbiol Infect Dis 2005; 52: 2934.
  • 20
    Pagano L, Caira M, Offidani M et al. Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). J Antimicrob Chemother 2010; 65: 20132018.
  • 21
    Sa MB, Zaragoza R. Critical overview of clinical guidelines relating to invasive fungal infections. Int J Antimicrob Agents 2008; 32 (suppl 2): S155S159.
  • 22
    Ananda-Rajah MR, Slavin MA, Thursky KT. The case for antifungal stewardship. Curr Opin Infect Dis 2012; 25: 107115.